| Kyle Chestnas, | |
|
40 Thf Blvd, Chesterfield, MO 63005-1150 | |
| (636) 536-6215 | |
| Not Available |
| Full Name | Kyle Chestnas |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 40 Thf Blvd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144686932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 021324 (Louisiana) | Secondary |
| 183500000X | Pharmacist | 2018015649 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Chestnas, 8455 Fern Ave Apt 1912, Shreveport, LA 71105-5790 Ph: (314) 477-2334 | Kyle Chestnas, 40 Thf Blvd, Chesterfield, MO 63005-1150 Ph: (636) 536-6215 |
News Archive
The University of Manchester, GlaxoSmithKline and AstraZeneca announce today the creation of the Manchester Collaborative Centre for Inflammation Research, a unique collaboration to establish a world-leading translational centre for inflammatory diseases. The project starts out with an initial investment of -5M from each partner over a three year period.
Biostar Pharmaceuticals, Inc., the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule, and other pharmaceutical products, announced today it has received new advertising approval from Shaanxi State Food and Drug Administration for marketing Xin Aoxing Oleanolic Acid Capsules.
Repligen Corporation announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Wednesday, December 9th, 2009 at 8:30 a.m. EST, to discuss results of its Phase 3 clinical trial of RG1068 in MRI imaging of the pancreas.
Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can be found that targets the problematic protein, they say, it could help smooth treatment for patients with conditions ranging from prostate cancer to diabetes to HIV
› Verified 4 days ago
Alexander Fred Wood, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14805 N Outer 40 Rd, Chesterfield, MO 63017 Phone: 636-733-7333 | |
Dr. Stephanie R Pieszchalski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14528 S Outer 40 Rd, Suite 300, Chesterfield, MO 63017 Phone: 314-810-8302 | |
Danielle Christine Chamness, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14805 North Outer 40 Rd Ste 140, Chesterfield, MO 63017 Phone: 636-733-7333 | |
Geizy Momanyi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 917 Chesterfield Pkwy E, Chesterfield, MO 63017 Phone: 636-532-5222 | |
Christina Jeanette Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 739 Goddard Ave, Chesterfield, MO 63005 Phone: 636-534-6800 Fax: 636-534-6797 | |
Edgardo Alvira, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17877 Chesterfield Airport Rd, Chesterfield, MO 63005 Phone: 636-544-2475 | |
Mr. Bradley Schammel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17877 Chesterfield Airport Rd, Chesterfield, MO 63005 Phone: 314-609-5376 |